Short- and long-term outcomes after distal pancreatectomy with radiologic infiltration of splenic vessels for pancreatic ductal adenocarcinoma
Gerardo Blanco-Fernández,Mario Serradilla-Martín,Fernando Rotellar,Raquel Latorre,Isabel Jaén-Torrejimeno,Elena Muñoz-Forner,Celia Villodre,Alberto Carabias-Hernández,Helga K. Kälviäinen-Mejía,Sara Esteban Gordillo,Roberto de la Plaza,Noelia De Armas-Conde,Marina Garcés-Albir,Silvia Carbonell Morote,Alba Manuel-Vázquez,Alejandro Serrablo,Fernando Pardo,Luis Sabater,María Paloma Sanz Muñoz,Jose M. Ramia
DOI: https://doi.org/10.1016/j.gassur.2024.01.018
2024-01-01
Journal of Gastrointestinal Surgery
Abstract:Background The impact on survival of radiological splenic vessel involvement (RSVI) in patients with pancreatic adenocarcinoma (PDAC) located in the body and tail of the pancreas is controversial, and its influence on postoperative morbidity after distal pancreatectomy (DP) is unknown. The aim of the present study is to determine the influence of RSVI on postoperative complications, overall survival (OS), and disease-free survival (DFS) in patients undergoing DP for PDAC. Methods Multicenter retrospective study of DP carried out at seven hepato-pancreato-biliary units between January 2008 and December 2018. Patients were classified according to the presence of RSVI. A Clavien-Dindo score >II was considered to represent a major complication. Results Ninety-five patients were included in the analysis. Forty-seven had vascular infiltration: four arterial, 10 venous and 33 had both arterial and venous involvement. The rate of major complications was 20.8% in patients without RSVI vs. 40% in those with venous RSVI, 25% in those with arterial RSVI and 30.3% in those with both arterial and venous RSVI (p=0.024). The DFS rates at 3years were 56% in the group without RSVI, 50% in the group with arterial RSVI, and 16% in the group with both arterial and venous RSVI (p=0.003). The OS rates at 3 years were 66% in the group without RSVI, 50% in the group with arterial RSVI, and 29% in the group with both arterial and venous RSVI (p<0.0001). Conclusions RSVI increases major complication rates after PD and reduces OS and DFS. It may therefore be a useful prognostic marker in patients with PDAC scheduled to undergo DP and may help to select patients likely to benefit from neoadjuvant treatment.
gastroenterology & hepatology,surgery